Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generic drugs
Pharma
Supreme Court rejects Vanda's Hetlioz patent revival appeal
The U.S. Supreme Court has rebuffed Vanda's bid to revive patents on its 10-year-old sleep disorder drug Hetlioz following a 2023 appeals court loss.
Fraiser Kansteiner
Apr 22, 2024 3:49pm
Teva CEO Richard Francis earns $25.7M thanks to welcome package
Apr 17, 2024 1:00pm
Generics face 'knowledge gap' against brand loyalty: GlobalData
Apr 8, 2024 12:09pm
Apotex buys specialty drugmaker Searchlight in expansion move
Apr 3, 2024 12:41pm
Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
Mar 29, 2024 1:10pm
Sandoz to shutter Eon Labs site acquired nearly 20 years ago
Feb 8, 2024 1:56pm